MYLIP and breast carcinoma: Thus, we reported that a novel regulatory pathway composed of TUSC8/miR-190b-5p/ MYLIP was involved in the progression of breast cancer, providing us novel insights and avenues for searching potential biomarkers and therapeutic targets for breast cancer diagnosis and treatment.